We are live on
!
Find out more
Avior Wealth Management Portfolio holdings
AUM
$3.79B
Turnover
13.85%
1-Year Est. Return
15.36%
This Fund
S&P 500
This Quarter
Est. Return
+6.49%
1 Year Est. Return
+15.36%
3 Year Est. Return
+71.45%
5 Year Est. Return
+69.28%
10 Year Est. Return
+233.16%
AUM
$995M
AUM Growth
+$59.4M
(+6.4%)
Cap. Flow
-$4.54M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,181
New
111
Increased
308
Reduced
321
Closed
72
Avg Time Held
2.7
years
Top 10 Avg Time Held
3.6
years
Top 20 Avg Time Held
3.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$4.86M |
| 2 |
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$2.18M |
| 3 |
iShares Core Dividend Growth ETF
DGRO
|
+$1.93M |
| 4 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$1.9M |
| 5 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$4.74M |
| 2 |
iShares Asia 50 ETF
AIA
|
+$2.2M |
| 3 |
Vanguard S&P 500 Value ETF
VOOV
|
+$1.88M |
| 4 |
CLGX
Corelogic, Inc.
CLGX
|
+$1.37M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.57% |
| 2 | Technology | 7.61% |
| 3 | Financials | 7.41% |
| 4 | Industrials | 5.15% |
| 5 | Healthcare | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PAYA
326
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $413K | 0.04% |
37,508
+2,122
| +6% | +$22.6K |
2020 Q4
2 quarters
|
|
327
CBRE Group
CBRE
$39.2B
| $412K | 0.04% |
4,815
+1,200
| +33% | +$102K |
2017 Q4
14 quarters
|
|
328
Merck
MRK
$358B
| $412K | 0.04% |
5,310
-255
| -5% | -$19K |
2015 Q2
24 quarters
|
|
329
Xtrackers Russell US Multifactor ETF
DEUS
$297M
| $403K | 0.04% |
9,129
-354
| -4% | -$15.5K |
2020 Q2
4 quarters
|
|
330
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.86B
| $402K | 0.04% |
11,364
| – | – |
2020 Q1
5 quarters
|
|
331
Ford
F
$49.1B
| $395K | 0.04% |
26,629
+3,265
| +14% | +$43.4K |
2014 Q1
29 quarters
|
|
332
DELISTED
Hanesbrands
HBI
| $393K | 0.04% |
21,100
+1,300
| +7% | +$25.7K |
2017 Q4
14 quarters
|
|
333
Linde
LIN
$227B
| $393K | 0.04% |
1,361
+20
| +1% | +$5.83K |
2019 Q2
8 quarters
|
|
334
CVS Health
CVS
$118B
| $391K | 0.04% |
4,700
+4,289
| +1,044% | +$351K |
2014 Q1
29 quarters
|
|
335
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $387K | 0.04% |
3,168
+822
| +35% | +$102K |
2019 Q1
9 quarters
|
|
336
PNC Financial Services
PNC
$85.7B
| $383K | 0.04% |
2,014
+101
| +5% | +$19K |
2017 Q3
15 quarters
|
|
337
Ingredion
INGR
$6.13B
| $380K | 0.04% |
+4,200
| New | +$392K |
2021 Q2
0 quarters
|
|
338
Rocket Pharmaceuticals
RCKT
$259M
| $379K | 0.04% |
8,577
+49
| +0.6% | +$2.13K |
2019 Q2
8 quarters
|
|
339
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.61B
| $372K | 0.04% |
3,356
-75
| -2% | -$8.27K |
2020 Q2
4 quarters
|
|
340
LGI Homes
LGIH
$1.02B
| $367K | 0.04% |
2,269
-2,163
| -49% | -$358K |
2019 Q1
9 quarters
|
|
341
Thermo Fisher Scientific
TMO
$258B
| $367K | 0.04% |
729
-65
| -8% | -$30.7K |
2017 Q4
14 quarters
|
|
342
Yum China
YUMC
$15.1B
| $357K | 0.04% |
5,407
-879
| -14% | -$56.1K |
2017 Q4
14 quarters
|
|
343
Truist Financial
TFC
$56.9B
| $355K | 0.04% |
6,421
| – | – |
2019 Q2
8 quarters
|
|
344
Lam Research
LRCX
$347B
| $353K | 0.04% |
5,430
-760
| -12% | -$48K |
2020 Q1
5 quarters
|
|
345
iShares Core Moderate Allocation ETF
AOM
$1.94B
| $352K | 0.04% |
7,818
-2
| -0% | -$89 |
2016 Q2
20 quarters
|
|
346
Phillips 66
PSX
$115B
| $352K | 0.04% |
4,108
+40
| +1% | +$3.38K |
2014 Q1
29 quarters
|
|
347
iShares 7-10 Year Treasury Bond ETF
IEF
$41.7B
| $340K | 0.03% |
2,905
-373
| -11% | -$42.7K |
2013 Q4
30 quarters
|
|
|
ZEN
348
DELISTED
ZENDESK INC
ZEN
| $340K | 0.03% |
2,359
-350
| -13% | -$49.4K |
2021 Q1
1 quarter
|
|
349
Pacific Biosciences
PACB
$609M
| $339K | 0.03% |
9,708
+2,702
| +39% | +$78.6K |
2021 Q1
1 quarter
|
|
350
Boston Scientific
BSX
$64B
| $338K | 0.03% |
7,926
| – | – |
2017 Q1
17 quarters
|
|
Similar funds
Avior Wealth Management's Q2 2021 Portfolio in Review
As of Q2 2021, Avior Wealth Management held 1,181 positions worth $995M, up 6.4% from $935M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Avior Wealth Management's Q2 2021 filing shows 111 new, 308 increased, 321 reduced and 72 closed positions. Its largest new stake was U.S. Targeted Value Portfolio ETF Class Shares: 36,439 shares worth $1.63M. The largest sale was State Street SPDR S&P 400 Mid Cap Value ETF, an estimated $4.74M.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 62% a quarter earlier, followed by Technology and Financials.
- Avior Wealth Management's largest Q2 2021 buy was U.S. Targeted Value Portfolio ETF Class Shares: 36,439 shares worth $1.63M.
- Avior Wealth Management added most to Vanguard Morningstar Growth ETF in Q2 2021, an estimated $4.86M increase.
- Avior Wealth Management's biggest Q2 2021 reduction was State Street SPDR S&P 400 Mid Cap Value ETF, cutting an estimated $4.74M.
- Avior Wealth Management fully exited iShares Asia 50 ETF in Q2 2021, selling an estimated $2.2M.
- Avior Wealth Management's ten largest holdings make up 28% of its $995M portfolio in Q2 2021.
- Avior Wealth Management opened 111 new positions and closed 72 in Q2 2021.
- Avior Wealth Management's portfolio value rose 6.4% quarter-over-quarter to $995M.
Based on Avior Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2021.